Drug-related AEs in at least 5% of patients
AE . | G1-G2 . | G3-G4 . | ||
---|---|---|---|---|
N . | % . | N . | % . | |
Platelet count decreased | 6 | 24 | 5 | 20 |
Anemia | 5 | 20 | 5 | 20 |
Neutrophil count decreased | 4 | 16 | 5 | 20 |
Cough | 7 | 28 | 0 | 0 |
Dyspnea | 4 | 16 | 2 | 8 |
Fatigue | 3 | 12 | 2 | 8 |
Nausea | 5 | 20 | 0 | 0 |
Diarrhea | 3 | 12 | 0 | 0 |
Vomiting | 3 | 12 | 0 | 0 |
Febrile neutropenia | 0 | 0 | 2 | 8 |
Chills | 2 | 8 | 0 | 0 |
Fever | 1 | 4 | 1 | 4 |
Hypoxia | 0 | 0 | 2 | 8 |
Rash maculo-papular | 1 | 4 | 1 | 4 |
AE . | G1-G2 . | G3-G4 . | ||
---|---|---|---|---|
N . | % . | N . | % . | |
Platelet count decreased | 6 | 24 | 5 | 20 |
Anemia | 5 | 20 | 5 | 20 |
Neutrophil count decreased | 4 | 16 | 5 | 20 |
Cough | 7 | 28 | 0 | 0 |
Dyspnea | 4 | 16 | 2 | 8 |
Fatigue | 3 | 12 | 2 | 8 |
Nausea | 5 | 20 | 0 | 0 |
Diarrhea | 3 | 12 | 0 | 0 |
Vomiting | 3 | 12 | 0 | 0 |
Febrile neutropenia | 0 | 0 | 2 | 8 |
Chills | 2 | 8 | 0 | 0 |
Fever | 1 | 4 | 1 | 4 |
Hypoxia | 0 | 0 | 2 | 8 |
Rash maculo-papular | 1 | 4 | 1 | 4 |
Decisions on whether the AE was related to the study drug were made by the treating physicians/investigators. A more detailed list of all AEs is provided in supplemental Table 1. n = 25.